Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2019-03-11 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is about informing the exchanges and public about planned investor meetings, including dates, participants, and venues. There is no financial data, report, or detailed presentation included, nor is there any mention of voting results, management changes, or legal matters. The document is essentially an announcement of scheduled investor meetings, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2019-03-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of a financial results conference call for Q3 and 9 months FY19 of Dr. Lal PathLabs Limited. It includes management speeches, financial performance highlights, and a Q&A session with investors and analysts. The presence of detailed financial data, operational updates, and forward-looking statements typical of earnings calls confirms this is a Call Transcript. The document references the SEBI regulation for disclosure and is addressed to stock exchanges, further supporting this classification. The length and content exclude it being a brief announcement or a report publication notice. Therefore, the document fits the category of a Call Transcript (CT).
2019-03-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content lists dates, names, venues, and types of meetings with investors. There is no financial data, no report attached or referenced as being published, and no mention of earnings or financial results. The document is an announcement of upcoming investor meetings, which fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Earnings Release or Investor Presentation. The document length is short (1833 characters), and it is not a report itself but an announcement of scheduled meetings.
2019-03-05 English
Resignation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of an independent director, Mr. Arun Duggal, from the company. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in the board of directors or senior management. The content is a straightforward announcement of a management change, not a detailed report or financial document. The document length is short (1896 characters), and it does not contain financial data or detailed management discussion. Therefore, it fits the category of Board/Management Information (MANG).
2019-03-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 70% confidence The document text is very short (704 characters) and contains a schedule of analyst/institutional investor meetings, including dates and types of meetings (One-on-One, Conference Call). There is no financial data, no detailed report content, and no indication of a full report or announcement of voting results, management changes, or legal proceedings. The content resembles a brief investor relations update or meeting schedule rather than a formal report or announcement. Given the nature of the content, it best fits the category of Investor Presentation (IP), as it relates to investor meetings and presentations, although it is minimal in detail. Confidence is moderate due to brevity but the content aligns best with IP rather than other categories.
2019-02-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 22, 2019, addressed to stock exchanges, informing about the schedule of upcoming analyst and institutional investor meetings. It explicitly states that no unpublished price sensitive information will be shared and that the schedule is available on the company's website. The content is an announcement of planned investor meetings rather than a financial report or detailed presentation. The document length is only 1761 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no discussion of results, no regulatory filings, or voting results. This fits the category of an Investor Presentation (IP) announcement or schedule notice. However, since it only provides the schedule of meetings and does not contain the actual presentation or detailed financial information, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement about investor meetings. The document does not fit other categories like Earnings Release or Management Reports because it lacks financial content. Therefore, the most appropriate classification is Regulatory Filings (RNS) with high confidence.
2019-02-22 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.